期刊文献+

单胺氧化酶抑制剂中间体1,2,3,4-四氢萘-1-胺盐酸盐的合成

Synthesis of monoamine oxidase inhibitor intermediate 1,2,3,4-tetrahydro-1-naphthylamine hydrochloride
下载PDF
导出
摘要 目的:设计一种以苯为原料合成单胺氧化酶(monoamine oxidase,MAO)抑制剂中间体1,2,3,4-四氢萘-1-胺盐酸盐的方法。方法:采用Fridel-Crafts酰化反应、Wolf-Kishner-黄明龙还原反应和Harwoth环合反应等方法,以苯为原料,经酰化、还原、环合、缩合、还原以及成盐制得1,2,3,4-四氢萘-1-胺盐酸盐(11)。结果:合成(11)的总收率为43.6%。结论:建立了合成MAO抑制剂中间体1,2,3,4-四氢萘-1-胺盐酸盐的方法,该方法具有原材料廉价易得、反应操作简便以及产品收率较高且品质好等优点,具有一定的工业化生产前景。 Objective:To design a method for synthesizing 1,2,3,4-tetrahydro-l-naphthalenamine hydrochloride, which is an impor-tant intermediate for monoamine oxidase (MAO) inhibitors. Methods: 1,2,3,4-tetrahydro-1-naphthylamine hydrochloride ( 11 ) was synthesized from benzene via acylation, reduction,cyclization, condensation, reduction,and salification by methods of Fridel Crafts acylation,Wolf-kishner-HUANG Minglong reduction and Harwoth cyclization. Results:Overall yield for synthesizing 1,2,3,4-te-trahydro-1-naphthylamine hydrochloride ( 11 ) was 43.6%. Conclusions: Method for synthesizing 1,2,3,4-tetrahydro - 1 -naphthale-namine hydrochloride is establish. Optimized synthetic route has advantages in industrial production for its cheap and readily available raw materials, easy in operation, high yield and high quality of products.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2013年第6期580-582,共3页 Journal of Chongqing Medical University
基金 国家科技重大专项课题"重大新药创制"资助项目(编号:2010ZX09401-306-1-1)
关键词 单胺氧化酶抑制剂 中间体 1 2 3 4-四氢萘-1-胺 合成 monoamine oxidase inhibitor intermediate 1 2 3 4-tetrahydro-1-naphthylamine hydrochloride synthesize
  • 相关文献

参考文献2

二级参考文献30

  • 1Ip N Y, Ip C F, Hu Y, et al. Preparation of acridine derivatives as cholinesterase inhibitors [ P ]. WO 2 008 091 901,2008.
  • 2Dirk G, Georg D, Henri D, et al. Preparation of as pipefidinobenzamides CGRP receptor antagonist [ P]. WO 2 009 065 919,2009.
  • 3Fink D M, Bores G M, Eflland R C, et al. Synthesis and evaluationof 5-amino-5,6,7,8-tetra-hydroquinolinones as potential agents for the treatment of alzheimer's disease[J]. J Med Chem,1995,38(18) :3645 -3651.
  • 4Martin Y C, Jarboe C H, Krause R A, et al. Potential anti-parkinson drugs designed by receptor mapping [J]. J Med Chem,1973,16(2) :147 - 150.
  • 5Wang S S, Sukenik C N. The reduction of oximes by lithium aluminum hydride in hexarnethylphosphoramide solvent [ J ]. J Org Chem, 1985,50 (25) :5448 - 50.
  • 6Tadanier J, Cole W. Preparation of the epimeric 3- aminoandrost-5-en-17-ones and 6-amino-3α, 5α-cycloandrostan-17-ones. The mechanism of the ammonolysisof steroid Δ^5-3β-toluenesulfonates [ J ]. J Org Chem, 1962,27 (12) :4624 - 4633.
  • 7Feuer H, Braunstein D M. Reduction of oximes,oxime ethers, and oxime esters with diborane. Novel synthesis of amines [J]. J Org Chem, 1969,34 (6) : 1817 - 1821.
  • 8Shepard E R, Noth J F, Porter H D, et al. Papaverine homologs. Ⅲ. The preparation of some 3-methylisoquinolines [ J ]. J Am Chem Soe, 1952, 74 ( 18 ) : 4611 -4615.
  • 9蔡茂军,沈竞康,唐希灿,等.一类四氢喹啉酮哌啶类化合物及其制备方法和用途[P].CN 01 132 147.4,2001.
  • 10Putkonen T, Tolvanen A, Jokela R. Total synthesis of (±)-tangutorine and ehiral HPLC separation of enantiomers [ J ]. Tetrahedron ,2003,59 (43) : 8589 - 8595.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部